Takeda plans 2,800 job cuts after Nycomed deal NEW YORK (AP) - Japanese drugmaker Takeda Pharmaceutical Co., which recently bought Swiss drugmaker Nycomed, says it will cut 2,800 jobs over the next five years. Takeda says it will cut 2,100 jobs in Europe and 700 in the U.S. The company says it will also combine or eliminate some subsidiaries, mostly in Europe. The release didn't say how many people it currently employs. Takeda is the biggest drugmaker in Japan, and it bought Nycomed in September to expand its access to emerging pharmaceutical markets like Asia, Latin America, and Russia. The company says it will diversify its range of products and focus on developing new ones, and devote fewer resources to older products. The cuts will be complete by early 2016 and Takeda says it will save 200 billion yen ($2.6 billion) a year in costs.